Keeping Medtech Real-World Evidence Real

article image

Meet Sandra Siami, the new head of NESTcc, the organization helping to drive and refine the use of real-world evidence by both regulators and industry, a trend accelerated by the COVID-19 pandemic and likely to remain when the crisis ends.

It is said that every crisis also creates opportunities. When it comes to COVID-19 and medtech, those opportunities appear largely to be taking the form of increased diagnostics applications, along with accelerating several process-based changes. Key among those is the increased use of telehealth services which has garnered much attention, but perhaps equally important is the development and growth of real-world data and evidence (RWE).

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: